13F-HR filed by GordonMD Global Investments LP
GordonMD Global Investments LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 16 holding rows worth $143,592,724.
- Accession
- 0000919574-26-003273
- Filer
- CIK 2039349
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 16 entries on the cover page, a total value of $143,592,724 stated on the cover page (in dollars after the unit check, H1), rows summing to $143,592,724 with VALUE read as dollars as filed, 13F file number 028-26511. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 4,244,818 | $36,632,779 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 737,550 | $22,215,006 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 1,518,552 | $13,606,226 | dollars as filed | |
| BAUSCH PLUS LOMB CORP | 071705107 | COMMON SHARES | 573,472 | $9,118,205 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 20,212 | $7,111,592 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 132,500 | $6,513,700 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 289,101 | $6,056,666 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 4,121,870 | $6,017,930 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,257,495 | $5,621,003 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 136,000 | $5,452,240 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 170,307 | $5,402,138 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 28,587 | $4,674,546 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 126,985 | $4,612,095 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 43,300 | $4,075,396 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 1,430,000 | $3,489,200 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 42,680 | $2,994,002 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-26-003273 | this filing | 2026-05-15 | acceptance time not in the bulk data set |